HCW Biologics (HCWB) Market Capitalization (2021 - 2026)

HCW Biologics (HCWB) has reported Market Capitalization for 6 consecutive years, with $6.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Market Capitalization rose 464.02% year-over-year to $6.6 million; the trailing twelve-month figure through Jun 2026 stood at $6.6 million (up 464.02% YoY), and the FY2025 full-year result was $339128.5, down 89.85% from the prior year.
• Market Capitalization advanced to $6.6 million in Q2 2026 per HCWB's latest filing, from $339128.5 in the prior quarter.
• Across five years, Market Capitalization topped out at $84.5 million in Q1 2025 and bottomed at $339128.5 in Q4 2025.
• Historically, Market Capitalization has averaged $12.4 million across 5 years, with a median of $8.4 million in 2023.
• The widest YoY moves for Market Capitalization: up 665.75% in 2025, down 89.85% in 2025.
• Over 5 years, Market Capitalization stood at $11.5 million in 2022, then slumped by 32.58% to $7.7 million in 2023, then sank by 56.75% to $3.3 million in 2024, then plunged by 89.85% to $339128.5 in 2025, then surged by 1853.99% to $6.6 million in 2026.
• According to Business Quant data, Market Capitalization over the past three periods registered $6.6 million, $339128.5, and $1.7 million for Q2 2026, Q4 2025, and Q3 2025 respectively.